ConCelltrate®100 has histologically demonstrated the presence of all five elements of bone formation including new bone, bone marrow, osteocytes, chondrocytes, and cartilage in the athymic rat post-implantation at 28 days. In-Vivo testing is performed by an independent laboratory on every lot post-sterilization.
In-vitro test results demonstrated up to 40x native BMP-2 alkaline phosphate levels compared to BMP-2 control.ConCelltrate ® 100
About ConCelltrate ® 100
ConCelltrate®100 is processed using a proprietary process.ConCelltrate®100 may be hydrated with saline, blood, BoneMarrow Aspirate (BMA), Platelet Rich Plasma (PRP), or other cellular components in accordance with a physician’s well-informed medical judgment. ConCelltrate®100 does not contain any extrinsic carriers and is entirely derived from100% human allograft bone
Potential Clinical Applications
- Foot & Ankle
Features & Benefits
- Tested for Osteoinductivity – each lot is assayed and verified
- Natural human scaffold
- 100% bone – no additional carrier
- Ambient storage and shipping temperatures
- Sterile – Sterility Assurance Level (SAL) of 10-6 with a Two Year Shelf Life
Discover MORE CONFIDENCE with CONCELLTRATE ® 100
(Available in Jar) ConCelltrate® 100
|ConCelltrate® 100, 1.0 cc||453010|
|ConCelltrate® 100, 2.5 cc||453025|
|ConCelltrate® 100, 5.0 cc||453050|
|ConCelltrate® 100, 10 cc||453100|
Cygnus®is a Registered Trademark of Vivex Biomedical Inc.
Please refer to Instructions for use for description, handling, storage parameters, indications, contraindications, warnings, precautions, and other important information. A surgeon must always rely on his or her own professional clinical judgment when deciding whether to use a particular product when treating a particular patient.